Tower Research Capital »

Monte Rosa Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $50k 14k 3.74
2024-03-31 $3.7k 522 7.05
2023-09-30 $82k 17k 4.79
2023-06-30 $11k 1.7k 6.85
2023-03-31 $18k 2.3k 7.68
2022-12-31 $11k 1.5k 7.55
2022-09-30 $121k 15k 8.16
2022-06-30 $70k 7.2k 9.66
2022-03-31 $37k 2.6k 14.15
2021-12-31 $9.0k 458 19.65
2021-09-30 $32k 1.4k 22.76
2021-06-30 $9.0k 400 22.50